The Board granted a 30 percent initial evaluation for obstructive sleep apnea (OSA) with persistent daytime hypersomnolence from August 8, 2018, to October 26, 2022, and a 50 percent evaluation for OSA requiring the use of a CPAP from October 27, 2022, to August 30, 2023.

The deciding factor: The Board found that it was factually ascertainable that the Veteran's OSA symptoms included persistent daytime hypersomnolence as of August 8, 2018, and required the use of a CPAP as of October 27, 2022.

Claimed conditions

obstructive sleep apnea (OSA) with persistent daytime hypersomnolence, obstructive sleep apnea (OSA) with a continuous positive airway pressure (CPAP)

How they argued it

Direct service connection

Exposure basis

None

Rating assigned

None in this decision

Decision date

November 4, 2025

Citation

A25095807

Want to see how appeals like this one tend to go? Appeals like mine